Diabetes Care

Journal

Publication Venue For

  • A shift toward a plant-centered diet from young to middle adulthood and subsequent risk of type 2 diabetes and weight gain: The coronary artery risk development in young adults (cardia) study.  43:2796-2803. 2020
  • Efficacy and safety of liraglutide 3.0 mg in individuals with overweight or obesity and type 2 diabetes treated with basal insulin: The SCALE insulin randomized controlled trial.  43:1085-1093. 2020
  • Optimization of metformin in the GRADE cohort: Effect on glycemia and body weight.  43:940-947. 2020
  • Genetic discrimination between LADA and childhood-onset type 1 diabetes within the MHC.  43:418-425. 2020
  • Prediabetes and risk for cardiovascular disease by hypertension status in black adults: The Jackson Heart Study.  42:2322-2329. 2019
  • Does the association of diabetes with stroke risk differ by age, race, and sex? Results from the reasons for geographic and racial differences in stroke (REGARDS) study.  42:1966-1972. 2019
  • Testosterone therapy in men with hypogonadism prevents progression from prediabetes to type 2 diabetes: Eight-year data from a registry study.  42:1104-1111. 2019
  • Risk factors for kidney disease in type 1 diabetes.  42:883-890. 2019
  • Type 1 diabetes risk in African-ancestry participants and utility of an ancestry-specific genetic risk score.  42:406-415. 2019
  • Nutrition therapy for adults with diabetes or prediabetes: A consensus report.  42:731-754. 2019
  • Impact of peer support on acute care visits and hospitalizations for individuals with diabetes and depressive symptoms: A cluster-randomized controlled trial.  41:2463-2470. 2018
  • A comparison of the 2017 American College of Cardiology/American Heart Association blood pressure guideline and the 2017 American diabetes association diabetes and hypertension position statement for U.S. adults with diabetes.  41:2322-2329. 2018
  • First genome-wide association study of latent autoimmune diabetes in adults reveals novel insights linking immune and metabolic diabetes.  41:2396-2403. 2018
  • A low-fat dietary pattern and diabetes: A secondary analysis from the women's health initiative dietary modification trial.  41:680-687. 2018
  • Duration of diabetes and prediabetes during adulthood and subclinical atherosclerosis and cardiac dysfunction inmiddle age: The CARDIA study.  41:731-738. 2018
  • Professional Practice Committee: Standards of medical care in Diabetesd2018.  41:S3. 2018
  • Diabetes and hypertension: A position statement by the American diabetes association.  40:1273-1284. 2017
  • Cardiometabolic disease staging predicts effectiveness of weight-loss therapy to prevent type 2 diabetes: Pooled results from phase III clinical trials assessing phentermine/topiramate extended release.  40:856-862. 2017
  • Update and next steps for real-world translation of interventions for type 2 diabetes prevention: Reflections from a diabetes care editors' expert forum. Diabetes care 2016;39:1186-1201.  40:e21-e22. 2017
  • Natriuretic peptide and high-sensitivity troponin for cardiovascular risk prediction in diabetes: The Atherosclerosis Risk in Communities (ARIC) study.  39:677-685. 2016
  • Erratum: Consequences of comorbidity of elevated stress and/or depressive symptoms and incident cardiovascular outcomes in diabetes: Results from the REasons for Geographic and Racial Differences in Stroke (REGARDS) study (Diabetes care (2016) 39 (101-109)).  39:495. 2016
  • Racial differences in the performance of existing risk prediction models for incident type 2 diabetes: The CARDIA study.  39:285-291. 2016
  • Ablation of the duodenal mucosa as a strategy for glycemic control in type 2diabetes: Role of nutrient signaling or simple weight loss.  39:2108-2110. 2016
  • Consequences of Comorbidity of Elevated Stress and/or Depressive Symptoms and Incident Cardiovascular Outcomes in Diabetes: Results from the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.  39:101-109. 2016
  • Cross-sectional and longitudinal associations between objectively measured sedentary time and metabolic Disease: The coronary artery risk development in young adults (CARDIA) Study.  38:1835-1843. 2015
  • Advances in the science, treatment, and prevention of the disease of obesity: Ref lections from a diabetes care editors' expert forum.  38:1567-1582. 2015
  • Mild gestational diabetes mellitus and long-term child health.  38:445-452. 2015
  • Hemoglobin a1c and the progression of coronary artery calcification among adults without diabetes.  38:66-71. 2015
  • Weight-loss therapy in type 2 diabetes: Effects of phentermine and topiramate extended release.  37:3309-3316. 2014
  • Impact of intensive lifestyle intervention on depression and health-related quality of life in type 2 diabetes: the Look AHEAD Trial..  37:1544-1553. 2014
  • Impact of an intensive lifestyle intervention on use and cost of medical services among overweight and obese adults with type 2 diabetes: The action for health in diabetes.  37:2548-2556. 2014
  • Metabolic syndrome, C-reactive protein, and mortality in U.S. blacks and whites: The reasons for geographic and racial differences in Stroke (REGARDS) study.  37:2284-2290. 2014
  • Prevention of type 2 diabetes in subjects with prediabetes and metabolic syndrome treated with phentermine and topiramate extended release.  37:912-921. 2014
  • Preventive measures for patients at risk for amputation from diabetes and peripheral arterial disease.  37. 2014
  • Ten nights of moderate hypoxia improves insulin sensitivity in obese humans.  37. 2014
  • The cross-sectional and longitudinal associations of diabetic retinopathy with cognitive function and brain MRI findings: The Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.  37:3244-3252. 2014
  • The look AHEAD trial: Bone loss at 4-year follow-up in type 2 diabetes.  37:2822-2829. 2014
  • Ten nights of moderate hypoxia improves insulin sensitivity in obese humans.  36. 2013
  • Response to comment on: Wing et al. Effect of intensive lifestyle intervention on sexual dysfunction in women with type 2 diabetes: Results from an ancillary look AHEAD study. Diabetes Care 2013;36:2937-2944.  36. 2013
  • Scientific statement: Socioecological determinants of prediabetes and type 2 diabetes.  36:2430-2439. 2013
  • Type 2 diabetes with partial lipodystrophy of the limbs: A new lipodystrophy phenotype.  36:2247-2253. 2013
  • Effect of intensive lifestyle intervention on sexual dysfunction inwomen with type 2 diabetes: Results from an ancillary look ahead study.  36:2937-2944. 2013
  • Awareness, treatment, and control of LDL cholesterol are lower among U.S. adults with undiagnosed diabetes versus diagnosed diabetes.  36:2734-2740. 2013
  • Duration of abdominal obesity beginning in young adulthood and incident diabetes throughmiddle age: The CARDIA study.  36:1241-1247. 2013
  • Four-year change in cardiorespiratory fitnessandinfluenceonglycemiccontrol in adults with type 2 diabetes in a randomized trial: The look AHEAD trial.  36:1297-1303. 2013
  • Limitations in the use of indices using glucose and insulin levels to predict insulin sensitivity: Impact of race and gender and superiority of the indices derived from oral glucose tolerance test in African Americans.  36:845-853. 2013
  • Association of electrocardiographically determined left ventricular mass with incident diabetes, 1985-1986 to 2010-2011.  36:645-647. 2013
  • Generic medications and blood pressure control in diabetic hypertensive subjects.  36:591-597. 2013
  • Association of prediabetes and diabetes with stroke symptoms: The reasons for geographic and racial differences in stroke (REGARDS) study.  35:1845-1852. 2012
  • Earlier onset and greater severity of disordered mineral metabolism in diabetic patients with chronic kidney disease.  35:994-1001. 2012
  • Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: Post hoc epidemiologic analysis of the ACCORD trial.  35:787-793. 2012
  • Insulin sensitizers may attenuate lean mass loss in older men with diabetes.  34:2381-2386. 2011
  • Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes.  34:1481-1486. 2011
  • Are the 2005 dietary guidelines for Americans associated with reduced risk of type 2 diabetes and cardiometabolic risk factors? Twenty-year findings from the CARDIA study.  34:1183-1185. 2011
  • Lack of association between 25(OH)D levels and incident type 2 diabetes in older women.  34:628-634. 2011
  • Maternal glucose concentration during pregnancy predicts fat and lean mass of prepubertal offspring.  34:741-745. 2011
  • The relation of diabetes, impaired fasting blood glucose, and insulin resistance to left ventricular structure and function in African Americans: The Jackson heart study.  34:507-509. 2011
  • Impact of A1C screening criterion on the diagnosis of pre-diabetes among U.S. adults.  33:2190-2195. 2010
  • Effect of the Look AHEAD study intervention on medication use and related cost to treat cardiovascular disease risk factors in individuals with type 2 diabetes.  33:1153-1158. 2010
  • Blood pressure control in diabetes: Temporal progress yet persistent racial disparities: National results from the REasons for Geographic and Racial Differences in Stroke (REGARDS) study.  33:798-803. 2010
  • Comparison of A1C and fasting glucose criteria to diagnose diabetes among U.S. adults.  33:95-97. 2010
  • Prevalence and risk factors for urinary incontinence in overweight and obese diabetic women: Action for Health in Diabetes (Look AHEAD) study.  32:1391-1397. 2009
  • Association of 20-year changes in cardiorespiratory fitness with incident type 2 diabetes: The Coronary Artery Risk Development in Young Adults (CARDIA) fitness study.  32:1284-1288. 2009
  • Oxidative stress and insulin resistance: The Coronary Artery Risk Development in Young Adults study.  32:1302-1307. 2009
  • First evidence of genetic association between AKT2 and polycystic ovary syndrome (Diabetes Care (2008) 31, (2284-2287)).  32:968. 2009
  • Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular rIsk factors the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial.  32:221-226. 2009
  • Biophysical correlates of cognition among depressed and nondepressed type 2 diabetic patients.  32:48-50. 2009
  • Physical activity may facilitate Diabetes prevention in Adolescents.  32:9-13. 2009
  • Risk factors related to inflammation and endothelial dysfunction in the dcct/edic cohort and their relationship with nephropathy and macrovascular complications.  31:2006-2012. 2008
  • Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose.  31:1007-1014. 2008
  • First evidence of genetic association between AKT2 and polycystic ovary syndrome.  31:2284-2287. 2008
  • Burden of comorbid medical conditions and quality of diabetes care.  30:2999-3004. 2007
  • Efonidipine simultaneously improves blood pressure, endothelial function, and metabolic parameters in nondiabetic patients with hypertension.  30:1605-1607. 2007
  • Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals with Type 2 Diabetes One-year results of the Look AHEAD trial.  30:1374-1383. 2007
  • Physical activity in U.S. adults with diabetes and at risk for developing diabetes, 2003.  30:203-209. 2007
  • Relationships of serum ferritin, transferrin saturation, and HFE mutations and self-reported diabetes in the hemochromatosis and iron overload screening (HEIRS) study.  29:2084-2089. 2006
  • Additive beneficial effects of fenofibrate combined with candesartan in the treatment of hypertriglyceridemic hypertensive patients.  29:195-201. 2006
  • Are health care professionals advising patients with diabetes or at risk for developing diabetes to exercise more?.  29:543-548. 2006
  • Obesity, inactivity, and the prevalence of diabetes and diabetes-related cardiovascular comorbidities in the U.S. 2000-2002.  28:1599-1603. 2005
  • Walking and type 2 diabetes.  28:1524-1525. 2005
  • Barriers to physical activity among predominantly low-income African-American patients with type 2 diabetes.  28:1209-1210. 2005
  • Epidemiology of ischemic stroke in patients with diabetes: The greater Cincinnati/Northern Kentucky stroke study.  28:355-359. 2005
  • Randomized effectiveness trial of a computer-assisted intervention to improve diabetes care.  28:33-39. 2005
  • Stockpiling of ovarian follicles and the response to rosiglitazone.  28:2333-2334. 2005
  • Effect of rosiglitazone versus insulin on the pancreatic β-cell function of subjects with type 2 diabetes.  27:2585-2589. 2004
  • Risk factors for metabolic syndrome: The Coronary Artery Risk Development in Young Adults (CARDIA) study, 1985-2001.  27:2707-2715. 2004
  • Estimation of resting energy expenditure considering effects of race and diabetes status.  27:1405-1411. 2004
  • Critical Evaluation of Adult Treatment Panel III Criteria in Identifying Insulin Resistance with Dyslipidemia.  27:978-983. 2004
  • The Effect of Vitamin Therapy on the Progression of Corona Artery Atherosclerosis Varies by Haptoglobin Type in Postmenopausal Women.  27:925-930. 2004
  • C-Reactive Protein and Glycemic Control in Adults with Diabetes: Response to King et al. [23] (multiple letters).  27:637-638. 2004
  • Efficacy of Conversion from Bedtime NPH Insulin Injection to Once- or Twice-Daily Injections of Insulin Glargine in Type 1 Diabetic Patients Using Basal/Bolus Therapy [20].  27:632-633. 2004
  • Intrinsic motivation and glycemic control in adolescents with type I diabetes [3].  27:1517. 2004
  • A descriptive and comparative study of the prevalence of depressive and anxiety disorders in low-income adults with type 2 diabetes and other chronic illnesses.  26:2311-2317. 2003
  • Fibrinogen is a marker for nephropathy and peripheral vascular disease in type 1 diabetes: Studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort.  26:1439-1448. 2003
  • Erratum: Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes (Diabetes Care (2002) 25 (1033-1041)).  26:971. 2003
  • Serum lipoproteins in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Intervention and Complications cohort: Associations with gender and glycemia.  26:810-818. 2003
  • Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes: A 1-year randomized controlled trial.  25:1033-1041. 2002
  • Oral contraceptive use and association with glucose, insulin, and diabetes in young adult women: The CARDIA study.  25:1027-1032. 2002
  • Oral contraceptive use and association with glucose, insulin, and diabetes in young adult women: the CARDIA Study. Coronary Artery Risk Development in Young Adults..  25:1027-1032. 2002
  • Prevalence and risk factors of microalbuminuria in a cohort of African-American women with gestational diabetes.  24:1764-1769. 2001
  • Prevalence of clinical and isolated subclinical cardiovascular disease in older adults with glucose disorders: The cardiovascular health study.  24:1233-1239. 2001
  • Bromocriptine: a novel approach to the treatment of type 2 diabetes.  23:1154-1161. 2000
  • Late-onset troglitazone-induced hepatic dysfunction [5].  23:128-129. 2000
  • The diabetes prevention program: Baseline characteristics of the randomized cohort.  23:1619-1629. 2000
  • Dual energy X-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome.  22:1310-1317. 1999
  • Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke.  22:1077-1083. 1999
  • Gastroparesis cured by gastrectomy [4].  22:1000-1001. 1999
  • Antidiabetic treatment trends in a cohort of elderly people with diabetes: The Cardiovascular Health Study, 1989-1997.  22:736-742. 1999
  • Diabetes and automobile crashes in the elderly: A population-based case- control study.  22:220-227. 1999
  • Multicenter randomized trial of a comprehensive prepared meal program in type 2 diabetes.  22:191-197. 1999
  • Troglitazone's effect on lipoprotein(a) levels [6].  22:859-860. 1999
  • Effect of postmenopausal hormone therapy on glucose and insulin concentrations.  21:1589-1595. 1998
  • Diabetes and accident insurance..  21:877-878. 1998
  • Metformin lowers lipoprotein(a) levels [1].  21:2028. 1998
  • Troglitazone interferes with gemfibrozil's lipid-lowering action [2].  21:2028-2029. 1998
  • Coronary artery disease in diabetic patients with lower-extremity arterial disease: Disease characteristics and survival: A report from the coronary artery surgery study (CASS) registry.  20:1381-1387. 1997
  • Nesidioblastosis causing reversal of insulin-dependent diabetes and development of hyperinsulinemic hypoglycemia.  18:1379-1380. 1995
  • Genes within the major histocompatibility complex predict NIDDM in African-American women in Alabama.  17:1491-1494. 1994
  • Glucose transport and NIDDM.  15:396-417. 1992
  • Microalbuminuria associated with diabetic neuropathy.  15:528-531. 1992
  • Condylomata acuminata in IDDM..  11:295-296. 1988
  • International Standard Serial Number (issn)

  • 0149-5992
  • Electronic International Standard Serial Number (eissn)

  • 0149-5992
  • 1935-5548